Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCRM in previously treated CLL and low-grade B-cell neoplasms
NCT00546377Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2005
- Primary completion
- May 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), follicular lymphoma (FL), Waldenstrom macroglobulinemia (WM), marginal zone lymphoma (MZL), sponsored by Memorial Sloan Kettering Cancer Center. Started Jul 2005; status: completed.
02
Drugs
mitoxantrone
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)follicular lymphoma (FL)Waldenstrom macroglobulinemia (WM)marginal zone lymphoma (MZL)
Beyond the preview
Go deeper on NCT00546377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546377.